Czechia· CZ-0279612
AUGTYRO
A repotrectinib product containing repotrectinib, registered in Czechia. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Repotrectinib is registered in 10 of 19 countries.
Countries holding a registration under ATC L01EX28 (repotrectinib), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Repotrectinib · ATC L01EX28
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- REPOTRECTINIB
- Manufacturer
- —
- Country
- Czechia (CZ)
- ATC code
- L01EX28
- ATC class
- Repotrectinib
- Defined daily dose
- 0.32 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Repotrectinib in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAugtyroE.R. Squibb & Sons, L.L.C.
- IrelandAUGTYRO 40 mg hard capsulesBristol-Myers Squibb Pharma EEIG
- IcelandAugtyroBristol-Myers Squibb Pharma EEIG
- BelgiumAugtyro 40 mgBristol-Myers Squibb Pharma
- NorwayAugtyroBristol-Myers Squibb Pharma EEIG
- PolandAugtyroBristol-Myers Squibb Pharma EEIG
- SwedenAugtyro 40 mg Kapsel, hårdBristol-Myers Squibb Pharma EEIG
- NetherlandsAUGTYRO 40 mg harde capsulesBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Augtyro
- Liechtenstein · Augtyro
- Norway · Augtyro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3770b3be-66e2-4252-9163-01ee2a17c375 GET /v1/drugs/3770b3be-66e2-4252-9163-01ee2a17c375?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": "40MG",
"pack_size": "120",
"substance": "REPOTRECTINIB",
"cz_kod_sukl": "0279612",
"product_type": "CH",
"substance_codes": "22161",
"registration_state": "F",
"registration_number": null
}See everything about repotrectinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.